SCHEMBL5447392

SCHEMBL5447392

Fc1cc(F)c2nc(Nc3ccc(Oc4ccc5nsnc5c4)cc3)[nH]c2c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSNK1A1 P48729 2/20 0.42
CSNK1D P48730 2/20 0.42
KDR P35968 9/20 0.39
RAF1 P04049 6/20 0.37
TEK Q02763 6/20 0.36
PDE10A Q9Y233 3/20 0.36
BRAF P15056 4/20 0.36
GSK3B P49841 1/20 0.35
CSNK1G2 P78368 1/20 0.35
IDH2 P48735 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
MCL1 Q07820 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5447181 0.89 RAF1 (0.44) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5465658 0.87 CSNK1A1 (0.42) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5466099 0.85 PDE10A (0.49) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5444103 0.84 CSNK1A1 (0.49) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5464185 0.83 CSNK1A1 (0.46) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5449925 0.80 KDR (0.49) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5459650 0.80 RAF1 (0.43) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5459667 0.78 SYK (0.44) CSNK1A1CSNK1DKDRPDE10AKDM4E
SCHEMBL5456254 0.74 RAF1 (0.44) CSNK1A1CSNK1DKDRRAF1TEK
SCHEMBL5454095 0.73 PDE10A (0.38) CSNK1A1CSNK1DKDRRAF1TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US claimed
US-20070021456-A1 Aminobenzimidazole derivatives MERCK PATENT GMBH (DE) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021456-A1 Aminobenzimidazole derivatives TIE1, KDR, FLT1 CSNK1A1 609/4885CSNK1D 627/4885KDR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.